Cancer Genetics Inc (NASDAQ:CGIX)

0.9917
Delayed Data
As of Jun 20
 -0.0083 / -0.83%
Today’s Change
0.82
Today|||52-Week Range
4.25
-46.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues10.2M18.0M27.0M29.1M
 
 
 
 
 
Cost of Goods Sold7.6M12.4M14.7M15.9M
 
 
 
 
 
Depreciation And Amortization838.6K1.7M2.4M2.2M
 
 
 
 
 
 
Operating ExpensesGross Income1.7M3.9M9.9M11.1M
 
 
 
 
 
General Expenses20.0M23.9M26.6M29.5M
 
 
 
 
 
Research And Development3.7M4.8M5.9M4.8M
 
 
 
 
 
Total Operating Expenses28.5M38.0M43.7M47.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.3M-20.0M-16.7M-18.5M
 
 
 
 
 
Extraordinary Credit615.0K511.0K1.7M0.00
 
 
 
 
Extraordinary Charge0.00-890.0K0.00-2.2M
 
 
 
Pre-Tax Equity Earnings-939.9K-707.0K-73.0K-22.0K
 
 
 
 
 
Interest Expense On Debt472.8K344.0K454.0K2.1M
 
 
 
 
 
Other Expenses0.000.00-325.0K-266.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.0M-21.4M-15.8M-23.0M
 
 
 
 
 
Income Taxes-2.4M-1.2M0.00-2.1M
 
 
 
 
Net Income-16.6M-20.2M-15.8M-20.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.4M10.3M15.9M20.7M
 
 
 
 
 
Shares To Calculate EPS Diluted9.5M10.3M15.9M20.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.80-$1.96-$1.00-$1.01
 
 
 
 
 
EPS Diluted-$1.80-$1.96-$1.00-$1.01